This site is intended for healthcare professionals only
LoginRegister
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon gets USFDA EIR for Visakhapatnam API facility
Lupin and TB Alliance Join Forces to Advance TelacebecJustify proposed dose and rationality: CDSCO Panel Tells Lupin on FDC Sacubitril plus Valsartan
Lupin receives positive EMA comittee opinion for eye therapy RanluspecLupin bags USFDA nod for Prednisolone Acetate Ophthalmic Suspension
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddy's Labs arm invests over Rs 2 lakh in Clean Renewable Energy KK 2A
GST Probe at Mankind Pharmas BSV Unit in MumbaiMankind Pharma Vice Chairman Juneja says BSV acquisition to aid future growth of Company
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSubmit clinical study data conducted in adults: CDSCO Panel Tells Sanofi on atopic dermatitis drug
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealCDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Antidiabetic Drug Tirzepatide
Novartis concludes acquisition of Tourmaline BioCDSCO panel Approves Novartis Protocol Amendment proposal to study inclisiran
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsEMA Committee recommends Rybrevant in combo with chemotherapy for adult patients with lung cancer...
Zydus Wellness net sales up by 31 percent in Q2 FY26Zydus Wellness registers 20 percent net sales growth in Q1
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsSubmit CT data of Liraglutide pre-filled pen for type 2 DM: CDSCO Panel Tells Biocon Pharma
Health Bulletin 03/ August/ 2024Health Bulletin 03/ August/ 2024
X